Company: BIAF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001840
Chunk: 95

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 95
---
 our Board of Directors
(our “Board”) may consider relevant. If we do not pay dividends, our Common Stock may be less valuable because a return on
your investment will occur only if our stock price appreciates.

Our Common Stock market price may never exceed the exercise price of our
outstanding warrants.

Each
Tradeable Warrant and Non-Tradeable Warrant that we issued in our initial public offering has an exercise price of $3.0625. Our other
outstanding warrants have exercise prices ranging from $1.50 to $7.35. In the event our Common Stock price does not exceed
the exercise price of the warrants during the period when they are exercisable, the warrants may not have any value.

 46 

Holders
of warrants have no rights as stockholders other than as set forth in the warrants until such holders exercise their warrants and acquire
our shares of Common Stock.

Until
holders of our warrants acquire shares of Common Stock upon exercise thereof, such holders will have no rights with respect to the shares
of Common Stock underlying the Warrants other than as set forth in the Warrants. Upon exercise of the warrants, the holders will be titled
to exercise the rights of a stockholder only as to matters for which the record date occurs after the date they were entered in the register
of members of the Company as a stockholder.

The warrant certificates governing our warrants designate the state and
federal courts of the State of New York sitting in the City of New York, Borough of Manhattan, as the exclusive forum for actions and
proceedings with respect to all matters arising out of the warrants, which could limit a warrant holder’s ability to choose the
judicial forum for disputes arising out of the warrants.

The warrant certificates governing our warrants provide that all legal
proceedings concerning the interpretations, enforcement, and defense of the transactions contemplated by the warrant certificate (whether
brought against a party to the warrant certificate or their respective affiliates, directors, officers, shareholders, partners, members,
employees, or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. The warrant certificates
further provide that we and the warrant holders irrevocably submit to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan, for the adjudication of any dispute under the warrant certificate or in connection with
it or with any transaction contemplated by it or discussed in it. Furthermore, we